Bone resorption by osteoclasts requires tight control, as overactivation reduces bone mass and strength. Stegen et al. demonstrate that α-ketoglutarate produced during serine synthesis promotes osteoclast development via metabolic–epigenetic coupling and could be a therapeutic target.
References
Sims, N. A. & Martin, T. J. Annu. Rev. Physiol. 82, 507–529 (2020).
Raisz, L. G. J. Clin. Invest. 115, 3318–3325 (2005).
Black, D. M. et al. N. Engl. J. Med. 383, 743–753 (2020).
Miller, P. D. et al. Bone 43, 222–229 (2008).
Ledesma-Colunga, M. G., Passin, V., Lademann, F., Hofbauer, L. C. & Rauner, M. Curr. Osteoporos. Rep. https://doi.org/10.1007/s11914-023-00825-3 (2023).
Stegen, S., Moermans, K., Stockmans, I., Thienpont, B. & Carmeliet, G. Nat. Metab. https://doi.org/10.1038/s42255-023-00948-y (2024).
Li, B. et al. FASEB J. 34, 11058–11067 (2020).
Park-Min, K. H. Semin. Immunopathol. 41, 565–572 (2019).
Yang, M. & Vousden, K. H. Nat. Rev. Cancer 16, 650–662 (2016).
Takayanagi, H. et al. Dev. Cell 3, 889–901 (2002).
Chaneton, B. et al. Nature 491, 458–462 (2012).
Pacold, M. E. et al. Nat. Chem. Biol. 12, 452–458 (2016).
Acknowledgements
Work in the laboratory of R.C.R. is supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (DK099134) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR077533) of the National Institutes of Health as well as the Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development (BX003724).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Riddle, R.C., Choquette, G.M. Serine synthesis promotes bone degradation. Nat Metab 6, 8–9 (2024). https://doi.org/10.1038/s42255-023-00949-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s42255-023-00949-x
- Springer Nature Limited